Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Silo Pharma, Inc. (SILO)

2.3   0.07 (3.14%) 06-09 14:19
Open: 2.26 Pre. Close: 2.23
High: 2.3 Low: 2.26
Volume: 4,192 Market Cap: 7(M)

Technical analysis

as of: 2023-06-09 1:47:31 PM
Short-term rate:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Mid-term rate:       
Target: Six months: 2.72     One year: 3.17
Support: Support1: 2.05    Support2: 1.87
Resistance: Resistance1: 2.32    Resistance2: 2.72
Pivot: 2.16
Moving Average: MA(5): 2.23     MA(20): 2.14
MA(100): 2.27     MA(250): 4.02
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 71.7     %D(3): 73.3
RSI: RSI(14): 56.2
52-week: High: 12.25  Low: 0.17
Average Vol(K): 3-Month: 26 (K)  10-Days: 9 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ SILO ] has closed below upper band by 20.4%. Bollinger Bands are 49.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 26 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.26 - 2.27 2.27 - 2.28
Low: 2.19 - 2.21 2.21 - 2.22
Close: 2.2 - 2.22 2.22 - 2.24

Company Description

Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University of Maryland, The Regents of the University of California, and Columbia University. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.

Headline News

Fri, 02 Jun 2023
Silo Pharma Announces Participation on Webull Corporate ... - GlobeNewswire

Tue, 09 May 2023
Silo Pharma's SPC-15 Awarded U.S. Patent Protecting Ongoing - GlobeNewswire

Mon, 24 Apr 2023
Silo Pharma to Present at Psychedelic Drug Development Conference - GlobeNewswire

Mon, 27 Mar 2023
Silo Pharma Announces filing of Patent for Treatment of Fibromyalgia - GlobeNewswire

Wed, 15 Mar 2023
Silo Pharma Announces Positive Results from IND-Enabling Study ... - GlobeNewswire

Fri, 03 Feb 2023
Silo Pharma, Mindset Pharma, Terran Biosciences Receive Psychedelic Treatments Patents, IP Portfolios Exp - Benzinga

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  PNK
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 3 (M)
% Held by Insiders 2.57e+006 (%)
% Held by Institutions 14.8 (%)
Shares Short 2 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -5
Return on Assets (ttm) 414.3
Return on Equity (ttm) -23.6
Qtrly Rev. Growth 72100
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth -1.8
Operating Cash Flow 0 (M)
Levered Free Cash Flow -3 (M)

Stock Valuations

PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow -0.67

Stock Dividends

Dividend 0
Forward Dividend 29480
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.